BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong F, Zhang W, Feng B, Zhang H, Rao H, Wang J, Cong X, Wei L. Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection. Virol J. 2015;12:100. [PMID: 26129991 DOI: 10.1186/s12985-015-0324-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Jiang BC, Liu X, Liu XH, Li ZS, Zhu GZ. Notch Signaling Regulates Circulating T Helper 22 Cells in Patients with Chronic Hepatitis C. Viral Immunol 2017;30:522-32. [PMID: 28410452 DOI: 10.1089/vim.2017.0007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gong J, Zhan H, Liang Y, He Q, Cui D. Role of Th22 Cells in Human Viral Diseases. Front Med (Lausanne) 2021;8:708140. [PMID: 34434945 DOI: 10.3389/fmed.2021.708140] [Reference Citation Analysis]
3 Comarmond C, Lorin V, Marques C, Maciejewski-Duval A, Joher N, Planchais C, Touzot M, Biard L, Hieu T, Quiniou V, Desbois AC, Rosenzwajg M, Klatzmann D, Cacoub P, Mouquet H, Saadoun D. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses. J Hepatol 2019;71:908-19. [PMID: 31279905 DOI: 10.1016/j.jhep.2019.06.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wu XL. Significance of CD4+CD25+CD127low/- regulatory T cells in hepatitis C. Shijie Huaren Xiaohua Zazhi 2016; 24(20): 3182-3187 [DOI: 10.11569/wcjd.v24.i20.3182] [Reference Citation Analysis]
5 Najafi Fard S, Schietroma I, Corano Scheri G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo G, Ceccarelli G, Scagnolari C, Vullo V, d'Ettorre G. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients. Clin Res Hepatol Gastroenterol 2018;42:319-29. [PMID: 29279268 DOI: 10.1016/j.clinre.2017.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
6 Konstantinides P, Alexopoulou A, Hadziyannis E, Kanellopoulou T, Dourakis SP. Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D. Ann Gastroenterol 2018;31:705-11. [PMID: 30386121 DOI: 10.20524/aog.2018.0310] [Reference Citation Analysis]
7 Portugal S, Obeng-Adjei N, Moir S, Crompton PD, Pierce SK. Atypical memory B cells in human chronic infectious diseases: An interim report. Cell Immunol 2017;321:18-25. [PMID: 28735813 DOI: 10.1016/j.cellimm.2017.07.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 16.4] [Reference Citation Analysis]